FFA
GSK icon

Founders Financial Alliance’s GSK GSK Stock Holding History

Founders Financial Alliance’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
5,327
+150
+3% +$7.93K 0.04% 359
2026
Q1 		$286K Buy
+5,177
New +$281K 0.05% 314
2025
Q4 		– Sell
-5,423
Closed -$234K – 652
2025
Q3 		$234K Buy
+5,423
New +$212K 0.04% 342
2025
Q2 		– Sell
-5,383
Closed -$209K – 572
2025
Q1 		$209K Sell
5,383
-614
-10% -$22.5K 0.05% 334
2024
Q4 		$203K Sell
5,997
-42
-0.7% -$1.51K 0.06% 275
2024
Q3 		$247K Buy
6,039
+1
+0% +$41 0.07% 250
2024
Q2 		$232K Hold
6,038
– – 0.07% 248
2024
Q1 		$259K Sell
6,038
-2,221
-27% -$91.6K 0.08% 222
2023
Q4 		$306K Sell
8,259
-360
-4% -$12.9K 0.12% 181
2023
Q3 		$312K Sell
8,619
-679
-7% -$24.1K 0.14% 162
2023
Q2 		$331K Buy
9,298
+2,501
+37% +$89.7K 0.13% 168
2023
Q1 		$244K Sell
6,797
-2,401
-26% -$84K 0.12% 176
2022
Q4 		$323K Sell
9,198
-68
-0.7% -$2.27K 0.15% 151
2022
Q3 		$273K Buy
9,266
+4,925
+113% +$187K 0.14% 162
2022
Q2 		$236K Sell
4,341
-1,291
-23% -$71.3K 0.12% 186
2022
Q1 		$307K Hold
5,632
– – 0.14% 155
2021
Q4 		$310K Buy
5,632
+1
+0% +$52 0.12% 178
2021
Q3 		$268K Hold
5,631
– – 0.13% 172
2021
Q2 		$279K Hold
5,631
– – 0.13% 185
2021
Q1 		$266K Buy
5,631
+245
+5% +$11.1K 0.13% 178
2020
Q4 		$246K Buy
5,386
+440
+9% +$20.2K 0.14% 163
2020
Q3 		$230K Buy
+4,946
New +$248K 0.14% 139

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Founders Financial Alliance's GSK Position: Q2 2026 in Review

Founders Financial Alliance increased its GSK (GSK) stake by 2.9% in Q2 2026, buying an estimated $7.93K and bringing the position to 5,327 shares worth $279K. The position accounts for 0.04% of the portfolio, ranked #359.

Founders Financial Alliance first reported a position in GSK in Q3 2020 and has held it in 22 quarters since. The position peaked at $331K in Q2 2023. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Founders Financial Alliance held 5,327 shares of GSK worth $279K as of Q2 2026.
  • Founders Financial Alliance bought 150 GSK shares in Q2 2026, an estimated $7.93K.
  • GSK made up 0.04% of Founders Financial Alliance's portfolio in Q2 2026, its #359 holding.
  • Founders Financial Alliance first reported a position in GSK in Q3 2020 and has held it in 22 quarters since.
  • Founders Financial Alliance's GSK position peaked at $331K in Q2 2023.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Founders Financial Alliance's 13F filing for Q2 2026, filed 4 Aug 2026.